What question did this study set out to answer?

Assess the relationship between vascular FDG-PET activity and clinical assessments in giant cell arteritis.

April 8, 2026

18F‐Fluorodeoxyglucose Positron Emission Tomography Imaging Assessment within a Randomized Controlled Trial in Giant Cell Arteritis

Key Points

Assess the relationship between vascular FDG-PET activity and clinical assessments in giant cell arteritis.
Conducted a randomized controlled trial
Utilized FDG-PET imaging for vascular assessment
Evaluated discordance between imaging and clinical findings
Identified instances where FDG-PET activity did not match clinical assessments
Indicated a need for further exploration of imaging outcomes in trials

Abstract

Vascular FDG-PET activity may be discordant with clinical assessment, particularly in subsets of patients with GCA. Imaging-based outcome measures should remain exploratory in future therapeutic trials.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Kaitlin A Quinn

Sovira Tan

Pauline Verdijk

Journals

Arthritis & Rheumatology

Actions

Institutions

KU Leuven

University of Tübingen

Friedrich-Alexander-Universität Erlangen-Nürnberg

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

18F‐Fluorodeoxyglucose Positron Emission Tomography Imaging Assessment within a Randomized Controlled Trial in Giant Cell Arteritis

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study

Also consider